A Phase I/II Study of RAD001 and Radiation Therapy in Patients With Brain Metastasis From Non-Small Cell Lung Cancer (NSCLC).
Phase of Trial: Phase I
Latest Information Update: 15 Oct 2014
At a glance
- Drugs Everolimus (Primary)
- Indications Brain metastases; Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 09 Mar 2012 Trial phase changed from I/II to I as reported by ClinicalTrials.gov.
- 09 Aug 2011 Planned end date changed from 1 Jan 2014 to 1 Feb 2011 as reported by ClinicalTrials.gov.
- 09 Aug 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.